Waldron Private Wealth LLC Seagen Inc. Transaction History

Waldron Private Wealth LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Aug 29, 2024	BUY	$191.51 - $216.16 $7,085 - $7,997	37 Added 3.03%	1,260 $267,000
Q3 2023 Oct 26, 2023	BUY	$191.51 - $216.16 $7,085 - $7,997	37 Added 3.03%	1,260 $267,000
Q2 2023 Aug 29, 2024	SELL	$187.64 - $206.25 $7,505 - $8,250	-40 Reduced 3.17%	1,223 $235,000
Q2 2023 Aug 07, 2023	SELL	$187.64 - $206.25 $7,505 - $8,250	-40 Reduced 3.17%	1,223 $235,000
Q1 2023 Aug 29, 2024	BUY	$127.59 - $203.08 $161,146 - $256,490	1,263 New	1,263 $255,000
Q1 2023 May 02, 2023	BUY	$127.59 - $203.08 $161,146 - $256,490	1,263 New	1,263 $255,000
Q2 2022 Aug 03, 2022	BUY	$108.81 - $179.33 $126,546 - $208,560	1,163 New	1,163 $205,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Waldron Private Wealth LLC with notifications on news.